Nasdaq:US$14.68 (+0.25) | HKEX:HK$23.26 (+0.38) | AIM:£2.20 (+0.01)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 其他業務 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture